首页> 外文期刊>Brazilian Journal of Infectious Diseases >Ventilator-associated pneumonia: the influence of bacterial resistance, prescription errors, and de-escalation of antimicrobial therapy on mortality rates
【24h】

Ventilator-associated pneumonia: the influence of bacterial resistance, prescription errors, and de-escalation of antimicrobial therapy on mortality rates

机译:呼吸机相关性肺炎:细菌耐药性,处方错误和抗菌药物降级对死亡率的影响

获取原文
           

摘要

Aim This study evaluated factors influencing mortality of patients with Ventilator-associated pneumonia (VAP), including bacterial resistance, prescription errors, and de-escalation of antibiotic therapy. Methods This retrospective study included 120 cases of Ventilator-associated pneumonia admitted to the adult adult intensive care unit of the Federal University of Uberl?¢ndia. The chi-square test was used to compare qualitative variables. Student's t -test was used for quantitative variables and multiple logistic regression analysis to identify independent predictors of mortality. Findings De-escalation of antibiotic therapy and resistant bacteria did not influence mortality. Mortality was 4 times and 3 times higher, respectively, in patients who received an inappropriate antibiotic loading dose and in patients whose antibiotic dose was not adjusted for renal function. Multiple logistic regression analysis revealed the incorrect adjustment for renal function was the only independent factor associated with increased mortality. Conclusion Prescription errors influenced mortality of patients with Ventilator-associated pneumonia, underscoring the challenge of proper Ventilator-associated pneumonia treatment, which requires continuous reevaluation to ensure that clinical response to therapy meets expectations.
机译:目的这项研究评估了影响呼吸机相关性肺炎(VAP)患者死亡率的因素,包括细菌抵抗力,处方错误和抗生素治疗的降级。方法这项回顾性研究包括120例呼吸机相关性肺炎,该病例被纳入Uberl?ndia联邦大学的成人成人重症监护病房。卡方检验用于比较定性变量。学生的t检验用于定量变量和多元逻辑回归分析,以识别死亡率的独立预测因子。研究结果抗生素治疗和耐药菌的降级没有影响死亡率。接受不合适的抗生素负荷剂量的患者和未根据肾脏功能调整抗生素剂量的患者的死亡率分别高出4倍和3倍。多元logistic回归分析显示,肾功能的不正确调节是与死亡率增加相关的唯一独立因素。结论处方错误影响了呼吸机相关性肺炎患者的死亡率,强调了正确进行呼吸机相关性肺炎治疗的挑战,需要不断地重新评估以确保对治疗的临床反应符合预期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号